News | April 21, 2014

Prostate Carcinoma Is the Most Frequent Diagnosis Treated at Proton Therapy Center Czech

The center in Prague offers noninvasive, outpatient treatment with 97 percent curability

Prostate Cancer Czech Proton Therapy Center Diagnosis Treatment

April 21, 2014 — Proton Therapy Center Czech is located in the capital of the Czech Republic and has successfully entered its second year of operation. Since the beginning, it has made itself available to patients from all over the world has to date has treated patients from 18 different countries — including Great Britain, France, Belgium, Germany, Norway, Switzerland and the Russian federation. The mix of clinical indications corresponds with world trends — half of the patients treated were with prostate cancer. For them proton therapy offers a new revolutionary chance for a smooth recovery and a rapid return to their usual daily lives following treatment.

Thus far, oncology patients have undergone proton therapy with no complications and the detailed examinations given after treatment only confirm that their health improving and they have great perspectives on their future quality of life without undesirable treatment-related side effects — that are often associated with the conventional radiation methods.

Proton Therapy Center Czech in Prague utilizes the most advanced form of proton therapy scanning available today — in the form of what is simply referred to as pencil beam scanning. This remarkable tool enables tumor treatment with millimeter precision, without damaging to surrounding healthy structures. Additionally all diagnostic methods including positron emission tomography/computed tomography (PET/CT) are available in a single, centralized location. Therefore examinations and planning times are shortened by up to 14 days. It is well established fact that surgery and conventional radiotherapy using photons (X-rays), can cause serious long-term side effects such as erectile dysfunction, loss of fertility, as well as various forms of urinary incontinence, rectal inflammation and bleeding, and intestinal fibrosis. While conventional X-ray radiation unnecessarily exposes up to 50 percent more health tissue to unwanted radiation, protons on the other hand can be precisely focused only upon the tumor without damaging sensitive health organs and tissues around it. Last but not least, the majority of patients are able to maintain their sexual potency.

Ji?í Kubeš, Ph.D., Head of Proton Therapy at Proton Therapy Center Czech said, “Proton radiotherapy offers the highest chance for maintaining sexual potency after treatment. The percentage of those who suffer from incontinence is much smaller than after surgery. A very low dose of radiation decreases the risk of damage to intestines. From our treatment experience thus far, the acute complications regress 14 days following the end of treatment. This means that none of our patients were forced to limit his or her life and work activities during treatment. Patients have not needed to go on sick leave at all during their treatment.“

The excellent results of treatment of prostate can be demonstrated by the new report from Washington by National Association for Proton Therapy.

For more information: www.proton-therapy.org

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Overlay Init